ETR:SBS Stratec (SBS) Stock Price, News & Analysis €24.35 -1.10 (-4.32%) As of 03/31/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Stratec Stock (ETR:SBS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Stratec alerts:Sign Up Key Stats Today's Range€24.00▼€24.9050-Day Range€24.35▼€36.6052-Week Range€36.00▼€49.65Volume22,314 shsAverage Volume6,253 shsMarket Capitalization$292.53 millionP/E Ratio29.22Dividend Yield2.26%Price TargetN/AConsensus RatingN/A Company OverviewStratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.Read More… Remove Ads Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Email Address SBS Stock News HeadlinesStratec (ETR:SBS) Hasn't Managed To Accelerate Its ReturnsMarch 25, 2025 | finance.yahoo.comEQS-News: STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDARMarch 19, 2025 | markets.businessinsider.comTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.April 1, 2025 | American Alternative (Ad)Stratec Announces Changes to 2025 Financial CalendarMarch 19, 2025 | finance.yahoo.comEQS-News: STRATEC RECEIVES VALIDATION OF ITS CLIMATE TARGETS FROM THE SCIENCE BASED TARGETS INITIATIVE (SBTi)March 15, 2025 | markets.businessinsider.comInstitutional owners may consider drastic measures as Stratec SE's (ETR:SBS) recent €44m drop adds to long-term lossesFebruary 20, 2025 | finance.yahoo.comAre Stratec SE's (ETR:SBS) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?January 18, 2025 | finance.yahoo.comEQS-News: STRATEC TO PARTICIPATE IN THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCEJanuary 8, 2025 | markets.businessinsider.comSee More Headlines SBS Stock Analysis - Frequently Asked Questions How have SBS shares performed this year? Stratec's stock was trading at €29.80 at the start of the year. Since then, SBS stock has decreased by 18.3% and is now trading at €24.35. View the best growth stocks for 2025 here. What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO) and Berkshire Hills Bancorp (BHLB). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Devices Sub-IndustryUtilities Current SymbolETR:SBS CIKN/A Webwww.stratec.com Phone+49-7082-79160FaxN/AEmployees1,464Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€0.83 Trailing P/E Ratio29.22 Forward P/E Ratio6.77 P/E Growth10.43Net Income$9.89 million Net Margins4.00% Pretax MarginN/A Return on Equity4.36% Return on Assets4.09% Debt Debt-to-Equity Ratio66.97 Current Ratio2.52 Quick Ratio1.65 Sales & Book Value Annual Sales$247.60 million Price / Sales1.18 Cash Flow€1.02 per share Price / Cash Flow23.85 Book Value€18.74 per share Price / Book1.30Miscellaneous Outstanding Shares12,013,727Free FloatN/AMarket Cap$292.53 million OptionableNot Optionable Beta0.16 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (ETR:SBS) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Stratec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.